FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069477 [Registered on: 25/06/2024] Trial Registered Prospectively
Last Modified On: 25/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Effect of Patola-Nimbadi Basti in the Management of Psoriasis w.s.r. to Ekakushtha 
Scientific Title of Study   An Open Label Clinical Non-Randomized Study to Evaluate the Efficacy of Patola-Nimbadi Basti in the Management of Psoriasis w.s.r. to Ekakushtha 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Himanshu 
Designation  M D Panchkarma scholar  
Affiliation  Institute for Ayurved Studies and Research Umri Road Sector 08 Kurukshetra Haryana 136118 
Address  Room No. 69, First Floor, Department of Panchkarma, Institute for Ayurved Studies and Research,Shri krishna Ayush University,Sector 8, Umri Road, Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  7988781308  
Fax    
Email  himanshuvaday@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Ashish Mehta  
Designation  Professor 
Affiliation  Institute for Ayurved Studies and Research Umri Road Sector 08 Kurukshetra Haryana 136118 
Address  Room No 67,First Floor PG Department of Panchkarma, Institute for Ayurved Studies and Research, Shri Krishna Ayush University, Sector 8, Umri Road, Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  8950375285  
Fax    
Email  chairperson.pk@skau.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Himanshu 
Designation  M D Panchkarma Scholar 
Affiliation  Institute for Ayurved Studies and Research Umri Road Sector 08 Kurukshetra Haryana 136118 
Address  Room No. 69, First Floor, Department of Panchkarma, Institute for Ayurved Studies and Research,Shri krishna Ayush University,Sector 8, Umri Road, Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  7988781308  
Fax    
Email  himanshuvaday@gmail.com  
 
Source of Monetary or Material Support  
Institute for Ayurved Studies and Research,Shri krishna Ayush University Umri Road Sector 08 Kurukshetra Haryana 136118 
 
Primary Sponsor  
Name  Institute for Ayurved Studies and Research Umri Road Kurukshetra Haryana  
Address  Institute for Ayurved Studies and Research Shri Krishna Ayush University sector 08 Umri Road Kurukshetra Haryana 136118 India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Himanshu  Institute for Ayurved Studies and Research Umri Road Sector 08 Kurukshetra Haryana 136118  Opd No 29 First Floor Department of Panchkarma Institute for Ayurved Studies and Research Umri Road Sector 08 Kurukshetra Haryana 136118
Kurukshetra
HARYANA 
7988781308

himanshuvaday@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L409||Psoriasis, unspecified. Ayurveda Condition: EKAKUSHTHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Charak Samhita , Procedure details: Kala Basti in which total 16 Basti having 10 Anuvasana Basti of Goghrita and 6 Patol-Nimbadi Niruha basti were given to patient.Niruha Basti shall be given on empty stomach and Anuvasana Basti shall be given immediately after morning meal.)
(1) Medicine Name: Patol-Nimbadi Niruha, Reference: Ashtanga Sangrah kalpasthan 4 Shloka 24, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 400(ml), Frequency: od, Duration: 6 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Subjects presenting with clinical features of Psoriasis.
2. Patients suffering from psoriasis with less than 50% of the body surface involvement.
3. Subjects with chronicity of disease more than 6 months and less than 5 yrs.
4. The patient who is fit for Basti Karma (Basti Yogya).
 
 
ExclusionCriteria 
Details  1. Patient presenting with clinical features other than psoriasis like generalized skin
lesions, herpes simplex, herpes zooster, scabies, acne, urticaria and immunological
medicated skin diseases like pemphigus vulgaris, dermatitis herpetiformis, guttate
psoriasis, pustular psoriasis, lupus erythematous, psoriatic arthropathy etc.
2. Patient suffering from severe psoriasis with more than 50% of the body surface
involvement.
3. Patient with chronicity of disease less than 6 months and above 5 yrs.
4. Subjects of either sex age below 20 years and above 60 years.
5. Patient on medication like corticosteroids, phototherapy, biologics, antidepressant
and any other drugs that may have an influence on the outcome of the study .
6. Alcoholics or drug abusers.
7. Systemic Lupus Erythematous and other Auto Immune disorders.
8. Patients having systematic pathologies like cardiac diseases, renal diseases and
endocrine disorders.
9. Pregnant and lactating women.
10. Patient who are contra-indicated for Basti Karma (Basti Ayogya).
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relieve in the sign and symptoms of Psoriasis  45th day after treatment. 
 
Secondary Outcome  
Outcome  TimePoints 
1. To improve quality of life of patient.
2. Remove the stress factor of Psoriasis patient.
 
At 15th, 30th, 45th day after treatment. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Psoriasis is one of the most common dermatological diseases. It is a complex, chronic, multi-factorial, non-contagious inflammatory skin disease characterized by erythematous, sharply demarcated papules and rounded plaques, covered by silver shiny scale. Eka kushtha consists of sign and symptoms i.e. Aswedanam,Mahavastu and Matsya Shakalopam  Avastha which can be compared with Psoriasis and hence it has been taken analogue to Psoriasis in present research work. In present study, Basti Chikitsa is selected because Acharya Sushrut described the indication of Basti in sansargaj and sannipataj vikara. Due to dominance of Tridosha in Kushtha and mainly Vata, Kapha in Eka Kushtha, favoured the treatment of Patola-Nimabadi Basti.The dravya of Patola-Nimbadi Basti is Tikta rasatmaka. Tikta dravya are Deepak, Pachak and Kaphaghna, Lekhan and Vishghana in nature and the effect on skin is Kandughna, Daha-Prashaman and Sthirikaran. Therefore, Patol-Nimbadi Basti is selected in management of Psoriasis

Aim: Evaluation of Patola-Nimbadi Basti in management of Psoriasis (Eka Kushtha). 

Objective: To Evaluate Efficacy of Patola-Nimbadi Basti in management of Psoriasis (Eka Kushtha). 

Research Hypothesis (H1):- Patola-Nimbadi Basti is effective in the management of Psoriasis (Eka Kushtha).

Null Hypothesis (H0):- Patola-Nimbadi Basti is not effective in the management of   Psoriasis (Eka Kushtha).

Study Plan:  30 patients will be selected of psoriasis on the basis of selection criteria. All patients will be given Patola-nimbadi Niruh basti and Goghrit Anuvasan basti as per the schedule of kala basti for 15 daya. Observations will be done on the basis of before and after subjective and objective parameters.

Analysis will be done after 15 days of Basti treatment and at 30th and 45th day as follow up.

 
Close